【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2089次   下载 2527 本文二维码信息
码上扫一扫!
同型半胱氨酸在大鼠血管平滑肌细胞上通过激活ERK1/2信号通路促进血管紧张素Ⅱ受体1表达
姜衡1△,于曼丽2△,魏勇1,欧阳平1,梁春3,吴宗贵3*
0
(1. 上海交通大学附属第一人民医院松江分院心内科, 上海 201600;
2. 第二军医大学长海医院心内科, 上海 200433;
3. 第二军医大学长征医院心内科, 上海 200003
共同第一作者
*通信作者)
摘要:
目的 观察同型半胱氨酸(homocysteine,Hcy)对大鼠血管平滑肌细胞(vascular smooth muscle cells,VSMCs)血管紧张素Ⅱ受体1(angiotensin Ⅱ receptor type 1,AT1R)蛋白表达的影响。方法 从大鼠胸主动脉分离、培养VSMCs,并用平滑肌特异性肌纤蛋白(α-SMA)进行免疫荧光鉴定;用10、100和300 μmol/L 3个不同浓度的Hcy孵育VSMCs,或在加入Hcy的同时加入5 μmol/L的ERK1/2通路阻断剂U0126,48 h后用免疫印迹法检测磷酸化的ERK1/2及AT1R的蛋白表达。结果 经鉴定,成功分离、培养VSMCs。10、100和300 μmol/L 3个不同浓度的Hcy均可上调VSMC的AT1R蛋白表达量(与溶剂对照组比较,P<0.05)。但3个浓度的Hcy组间差异无统计学意义(P>0.05)。10 μmol/L的Hcy可增加VSMC的ERK1/2磷酸化(P<0.05),激活ERK1/2信号通路。ERK1/2通路抑制剂U0126可完全阻断Hcy导致的ERK1/2磷酸化,并取消Hcy导致的AT1R上调。结论 Hcy可通过激活ERK1/2信号通路促进大鼠VSMC AT1R的表达,这一结果可能有助于揭示高Hcy血症与高血压的内在联系。
关键词:  高血压  同型半胱氨酸  血管平滑肌细胞  ERK1/2  血管紧张素Ⅱ受体1
DOI:10.3724/SP.J.1008.2014.00968
投稿时间:2014-04-01修订日期:2014-05-29
基金项目:上海市松江区科委科学技术攻关项目(12SJGGYY02).
Homocysteine upregulates angiotensin Ⅱ receptor type 1 (AT1R) expression via activating ERK1/2 signaling pathway in rat vascular smooth muscle cells
JIANG Heng1△,YU Man-li2△,WEI Yong1,OUYANG Ping1,LIANG Chun3,WU Zong-gui3*
(1. Department of Cardiology, The First People's Hospital of Shanghai(Songjiang Branch), Shanghai Jiaotong University, Shanghai 201600, China;
2. Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China;
3. Department of Cardiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
Co-first authors.
* Corresponding author.)
Abstract:
Objective To study the influence of homocysteine on the protein expression of angiotensin Ⅱ receptor type 1 (AT1R) in rat vascular smooth muscle cells (VSMCs). Methods Primary rat VSMCs were isolated and cultured in vitro and identified by detecting α-SMA expression with immunofluorescence technique. VSMCs were exposed to three different concentrations of homocysteine (10, 100 and 300 μmol/L) alone or in combination with U0126 (5 μmol/L, a potent inhibitor of ERK1/2) for 48 h, and then immunoblotting method was used to detect AT1R protein expression and phosphorylation of ERK1/2. Results Primary rat VSMCs (positive for α-smooth muscle actin [α-SMA] staining) were isolated and cultured successfully. All the three different concentrations of homocysteine (10, 100 and 300 μmol/L) induced significant AT1R protein expression (P<0.05 vs solvent control group) in VSMCs, but there was no significant difference between the three groups. Moreover, homocysteine at 10 μmol/L significantly activated phosphorylation of ERK1/2 in VSMCs (P<0.05 vs blank control). Supplement of U0126 not only blocked the phosphorylation of ERK1/2 induced by homocysteine, but also abolished homocysteine-induced upregulation of AT1R. Conclusion Our results in this study indicate that homocysteine can upregulate AT1R protein expression via activating ERK1/2 signaling pathway in rat VSMCs, which may help to illustrate the relation between Hcy and hypertension.
Key words:  hypertension  homocysteine  vascular smooth muscle cells  ERK1/2 signaling  angiotensin Ⅱ receptor type 1